Koss Olinger Consulting LLC Has $512,000 Stock Holdings in CVS Health Corporation $CVS

Koss Olinger Consulting LLC reduced its holdings in CVS Health Corporation (NYSE:CVS) by 6.9% in the 2nd quarter, according to the company in its most recent filing with the SEC. The firm owned 7,420 shares of the pharmacy operator’s stock after selling 548 shares during the quarter. Koss Olinger Consulting LLC’s holdings in CVS Health were worth $512,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in CVS. Avion Wealth increased its position in CVS Health by 99.0% in the 2nd quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock valued at $26,000 after acquiring an additional 189 shares during the period. Harbor Asset Planning Inc. acquired a new position in CVS Health in the 2nd quarter valued at approximately $30,000. Bell Investment Advisors Inc increased its position in CVS Health by 119.8% in the 1st quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator’s stock valued at $31,000 after acquiring an additional 248 shares during the period. Roxbury Financial LLC increased its position in CVS Health by 78.3% in the 2nd quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator’s stock valued at $32,000 after acquiring an additional 202 shares during the period. Finally, ORG Partners LLC increased its position in CVS Health by 418.9% in the 2nd quarter. ORG Partners LLC now owns 467 shares of the pharmacy operator’s stock valued at $32,000 after acquiring an additional 377 shares during the period. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at CVS Health

In other CVS Health news, Director Anne A. Finucane sold 7,500 shares of the firm’s stock in a transaction on Wednesday, August 20th. The shares were sold at an average price of $71.02, for a total value of $532,650.00. Following the transaction, the director directly owned 22,156 shares of the company’s stock, valued at approximately $1,573,519.12. This trade represents a 25.29% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 1.22% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have issued reports on CVS shares. Jefferies Financial Group upped their price target on shares of CVS Health from $80.00 to $92.00 in a research report on Wednesday, October 15th. UBS Group upped their price objective on shares of CVS Health from $79.00 to $96.00 and gave the company a “buy” rating in a research note on Friday. Mizuho upped their price objective on shares of CVS Health from $76.00 to $88.00 and gave the company an “outperform” rating in a research note on Thursday, October 9th. Wolfe Research upped their price objective on shares of CVS Health from $80.00 to $85.00 and gave the company an “outperform” rating in a research note on Monday, September 22nd. Finally, Sanford C. Bernstein upped their price objective on shares of CVS Health from $72.00 to $77.00 and gave the company a “market perform” rating in a research note on Friday, September 5th. Two investment analysts have rated the stock with a Strong Buy rating, twenty have assigned a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $83.38.

CVS Health Stock Up 0.6%

Shares of NYSE CVS opened at $82.44 on Tuesday. The firm has a market cap of $104.56 billion, a PE ratio of 23.03, a P/E/G ratio of 0.90 and a beta of 0.60. CVS Health Corporation has a 12-month low of $43.56 and a 12-month high of $83.52. The company’s fifty day simple moving average is $75.82 and its 200 day simple moving average is $68.75. The company has a quick ratio of 0.62, a current ratio of 0.80 and a debt-to-equity ratio of 0.74.

CVS Health (NYSE:CVS) last issued its earnings results on Thursday, July 31st. The pharmacy operator reported $1.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.46 by $0.35. The business had revenue of $98.92 billion for the quarter, compared to analyst estimates of $94.87 billion. CVS Health had a net margin of 1.17% and a return on equity of 10.51%. CVS Health’s revenue was up 8.4% on a year-over-year basis. During the same period in the prior year, the firm earned $1.83 earnings per share. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. As a group, sell-side analysts forecast that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, November 3rd. Investors of record on Thursday, October 23rd will be paid a dividend of $0.665 per share. The ex-dividend date of this dividend is Thursday, October 23rd. This represents a $2.66 annualized dividend and a yield of 3.2%. CVS Health’s dividend payout ratio is currently 74.30%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.